Raymond James Financial Services Advisors Inc. Has $308,000 Stock Position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Raymond James Financial Services Advisors Inc. raised its stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAYFree Report) by 32.2% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 7,697 shares of the medical instruments supplier’s stock after acquiring an additional 1,874 shares during the quarter. Raymond James Financial Services Advisors Inc.’s holdings in DENTSPLY SIRONA were worth $308,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the stock. Vanguard Group Inc. increased its position in DENTSPLY SIRONA by 1.2% in the 3rd quarter. Vanguard Group Inc. now owns 24,732,513 shares of the medical instruments supplier’s stock valued at $701,167,000 after acquiring an additional 297,487 shares in the last quarter. Artisan Partners Limited Partnership increased its position in DENTSPLY SIRONA by 1.1% in the 1st quarter. Artisan Partners Limited Partnership now owns 13,732,196 shares of the medical instruments supplier’s stock valued at $539,401,000 after acquiring an additional 149,912 shares in the last quarter. Morgan Stanley increased its position in DENTSPLY SIRONA by 2.4% in the 4th quarter. Morgan Stanley now owns 8,692,375 shares of the medical instruments supplier’s stock valued at $276,765,000 after acquiring an additional 205,096 shares in the last quarter. Price T Rowe Associates Inc. MD increased its position in DENTSPLY SIRONA by 18.6% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 7,802,326 shares of the medical instruments supplier’s stock valued at $306,476,000 after acquiring an additional 1,224,984 shares in the last quarter. Finally, Wellington Management Group LLP boosted its stake in shares of DENTSPLY SIRONA by 4.3% in the 1st quarter. Wellington Management Group LLP now owns 6,660,958 shares of the medical instruments supplier’s stock valued at $261,642,000 after purchasing an additional 274,979 shares during the last quarter. Institutional investors and hedge funds own 95.70% of the company’s stock.

DENTSPLY SIRONA Stock Up 2.3 %

DENTSPLY SIRONA stock opened at $29.21 on Friday. The company’s 50 day simple moving average is $33.70 and its 200 day simple moving average is $37.52. DENTSPLY SIRONA Inc. has a fifty-two week low of $26.27 and a fifty-two week high of $43.24. The firm has a market capitalization of $6.18 billion, a price-to-earnings ratio of -6.12, a PEG ratio of 1.76 and a beta of 0.99. The company has a debt-to-equity ratio of 0.50, a current ratio of 1.51 and a quick ratio of 0.99.

DENTSPLY SIRONA (NASDAQ:XRAYGet Free Report) last announced its quarterly earnings results on Thursday, November 2nd. The medical instruments supplier reported $0.49 earnings per share for the quarter, beating analysts’ consensus estimates of $0.48 by $0.01. DENTSPLY SIRONA had a negative net margin of 26.04% and a positive return on equity of 10.29%. The firm had revenue of $947.00 million for the quarter, compared to analyst estimates of $975.21 million. During the same quarter in the previous year, the firm posted $0.41 earnings per share. The business’s revenue was up .0% on a year-over-year basis. As a group, sell-side analysts anticipate that DENTSPLY SIRONA Inc. will post 1.97 EPS for the current year.

Wall Street Analysts Forecast Growth

Several research analysts have recently issued reports on the stock. Barrington Research reduced their target price on shares of DENTSPLY SIRONA from $51.00 to $41.00 and set an “outperform” rating on the stock in a research note on Friday. StockNews.com lowered shares of DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a research note on Monday, October 30th. Evercore ISI reduced their target price on shares of DENTSPLY SIRONA from $45.00 to $36.00 in a research note on Wednesday, October 11th. Stifel Nicolaus reduced their target price on shares of DENTSPLY SIRONA from $41.00 to $35.00 and set a “hold” rating on the stock in a research note on Wednesday. Finally, Piper Sandler reduced their target price on shares of DENTSPLY SIRONA from $42.00 to $39.00 and set a “neutral” rating on the stock in a research note on Friday, September 22nd. Five investment analysts have rated the stock with a hold rating and two have issued a buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus price target of $40.13.

Get Our Latest Research Report on DENTSPLY SIRONA

About DENTSPLY SIRONA

(Free Report)

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies for professional dental market worldwide. The company operates through two segments, Technologies & Equipment, and Consumables. The Technologies & Equipment segment provides dental equipment, such as treatment centers, imaging equipment, motorized dental handpieces, and other instruments for dental practitioners and specialists; dental CAD/CAM technologies for dental offices to support various digital dental procedures, including dental restorations; dentist-directed aligner solutions, SureSmile, and direct-to-consumer clear aligner solutions, as well as high frequency vibration technology device; implants; and urology catheters and other healthcare-related consumable products.

Featured Articles

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.